These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 21330386)

  • 1. Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era.
    Zhang R; Dai LZ; Xie WP; Yu ZX; Wu BX; Pan L; Yuan P; Jiang X; He J; Humbert M; Jing ZC
    Chest; 2011 Aug; 140(2):301-309. PubMed ID: 21330386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension.
    Ruiz-Cano MJ; Escribano P; Alonso R; Delgado J; Carreira P; Velazquez T; Sanchez MA; Sáenz de la Calzada C
    J Heart Lung Transplant; 2009 Jun; 28(6):621-7. PubMed ID: 19481024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of clinical characteristics and survival on patients with idiopathic pulmonary arterial hypertension and familial pulmonary arterial hypertension during conventional therapy era and targeted therapy era].
    Xu X; Sun M; Jiang X; Zhang R; Zhao Q; Wang Y; Sun K; Wang X; Peng F; Zheng L; Wen L; Jing Z
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jun; 42(6):465-8. PubMed ID: 25164218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension.
    Sadeghi S; Granton JT; Akhavan P; Pasarikovski CR; Roos AM; Thenganatt J; Moric J; Johnson SR
    Respirology; 2015 Apr; 20(3):481-7. PubMed ID: 25583377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension.
    Chung SM; Lee CK; Lee EY; Yoo B; Lee SD; Moon HB
    Clin Rheumatol; 2006 Nov; 25(6):866-72. PubMed ID: 16496078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension.
    Langleben D; Orfanos SE; Giovinazzo M; Hirsch A; Baron M; Senécal JL; Armaganidis A; Catravas JD
    Arthritis Rheum; 2008 Apr; 58(4):1156-64. PubMed ID: 18383374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: real-world insights.
    Dardi F; Manes A; Palazzini M; Bachetti C; Mazzanti G; Rinaldi A; Albini A; Gotti E; Monti E; Bacchi Reggiani ML; Galiè N
    Eur Respir J; 2015 Aug; 46(2):414-21. PubMed ID: 26022952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
    Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
    Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and prognostic factors in patients with connective tissue disease-associated pulmonary hypertension diagnosed by echocardiography: results from a Korean nationwide registry.
    Kang KY; Jeon CH; Choi SJ; Yoon BY; Choi CB; Lee CH; Suh CH; Lee CW; Cho CS; Nam EJ; Koh EM; Kim HY; Choi HJ; Kim HA; Jun JB; Lee J; Kim J; Ji JD; Min JK; Kim KJ; Shin K; So MW; Kwon SR; Kim SK; Nah SS; Kwok SK; Lee SK; Lee SW; Park SH; Park W; Park YB; Lee YH; Lee SS; Yoo DH
    Int J Rheum Dis; 2017 Sep; 20(9):1227-1236. PubMed ID: 26214170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
    Olsson KM; Delcroix M; Ghofrani HA; Tiede H; Huscher D; Speich R; Grünig E; Staehler G; Rosenkranz S; Halank M; Held M; Lange TJ; Behr J; Klose H; Claussen M; Ewert R; Opitz CF; Vizza CD; Scelsi L; Vonk-Noordegraaf A; Kaemmerer H; Gibbs JS; Coghlan G; Pepke-Zaba J; Schulz U; Gorenflo M; Pittrow D; Hoeper MM
    Circulation; 2014 Jan; 129(1):57-65. PubMed ID: 24081973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis.
    Hoeper MM; Dwivedi K; Pausch C; Lewis RA; Olsson KM; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Park DH; Ghofrani HA; Ewert R; Kaemmerer H; Kabitz HJ; Skowasch D; Behr J; Milger K; Lange TJ; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Eisenmann S; Schmidt KH; Swift AJ; Thompson AAR; Elliot CA; Rosenkranz S; Condliffe R; Kiely DG; Halank M
    Lancet Respir Med; 2022 Oct; 10(10):937-948. PubMed ID: 35777416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet level as a new prognostic factor for idiopathic pulmonary arterial hypertension in the era of combination therapy.
    Taguchi H; Kataoka M; Yanagisawa R; Kawakami T; Tamura Y; Fukuda K; Yoshino H; Satoh T
    Circ J; 2012; 76(6):1494-500. PubMed ID: 22447010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival in schistosomiasis-associated pulmonary arterial hypertension.
    dos Santos Fernandes CJ; Jardim CV; Hovnanian A; Hoette S; Dias BA; Souza S; Humbert M; Souza R
    J Am Coll Cardiol; 2010 Aug; 56(9):715-20. PubMed ID: 20723801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension complicated by pericardial effusion: a single center experience.
    Honeycutt GR; Safdar Z
    Ther Adv Respir Dis; 2013 Jun; 7(3):151-9. PubMed ID: 23258502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potts shunt in children with idiopathic pulmonary arterial hypertension: long-term results.
    Baruteau AE; Serraf A; Lévy M; Petit J; Bonnet D; Jais X; Vouhé P; Simonneau G; Belli E; Humbert M
    Ann Thorac Surg; 2012 Sep; 94(3):817-24. PubMed ID: 22704329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study.
    Ngian GS; Stevens W; Prior D; Gabbay E; Roddy J; Tran A; Minson R; Hill C; Chow K; Sahhar J; Proudman S; Nikpour M
    Arthritis Res Ther; 2012 Oct; 14(5):R213. PubMed ID: 23039366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension.
    Kylhammar D; Persson L; Hesselstrand R; Rådegran G
    Scand Cardiovasc J; 2014 Aug; 48(4):223-33. PubMed ID: 24912571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension.
    Fisher MR; Mathai SC; Champion HC; Girgis RE; Housten-Harris T; Hummers L; Krishnan JA; Wigley F; Hassoun PM
    Arthritis Rheum; 2006 Sep; 54(9):3043-50. PubMed ID: 16947776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characteristics of 161 Chinese patients with idiopathic pulmonary arterial hypertension].
    Jia WB; Jiang X; Zuo XR; He J; Zhao QH; Jiang R; Jing ZC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Aug; 40(8):652-6. PubMed ID: 23141008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Pericardial Effusion on Serial Echocardiograms in Pulmonary Arterial Hypertension.
    Batal O; Dardari Z; Costabile C; Gorcsan J; Arena VC; Mathier MA
    Echocardiography; 2015 Oct; 32(10):1471-6. PubMed ID: 25682779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.